Table 2. Metabolite concentrations [arbitrary units], estimated using the averaged spectra of PD patients and age-matched controls.
Controls (n = 24) | PD patients (n = 21) | |||
rostral | caudal | rostral | caudal | |
S/N | 46 | 41 | 41 | 38 |
FWHM (ppm) | 0.107 | 0.095 | 0.119 | 0.095 |
NAA+NAAG | 50.2 4% | 40.7 4% | 41.0 4% | 31.9 3% |
GPC+PCh | 5.4 2% | 6.3 2% | 5.2 3% | 5.6 2% |
Cr+PCr | 28.0 3% | 27.2 3% | 25.0 4% | 21.8 3% |
Ins+Gly | 27.2 6% | 21.8 8% | 21.9 8% | 19.1 9% |
Glu+Gln | 10.1 37% | 5.0 72% | 14.1 27% | 13.9 23% |
GABA+Hcs | 43.6 11% | 42.6 11% | 49.2 8% | 48.3 7% |
GABA | 21.1 18% | 18.4 18% | 31.8 15% | 21.7 15% |
GSH | 20.7 6% | 20.2 6% | 14.0 14% | 11.9 11% |
Dopamine | 12.5 17% | 12.1 17% | 7.8 37% | 2.8 78% |
HVA | 7.2 23% | 9.2 17% | 11.8 20% | 11.2 17% |
Also given are the Cramer-Rao lower bounds [%].